Back to Search
PETER NAVOLANIC, M.D.
M.D.
Adult Medicine Physician
NPI: 1427121896Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Neosis and its potential role in cancer development and chemoresistance.
PMID 14752274·Cancer Biol Ther·2004
7-preclinical
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
PMID 12646938·Leukemia·2003
5-case
EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
PMID 12527919·Int J Oncol·2003
6-review
Identification of isoforms of a mitotic motor in mammalian spermatogenesis.
PMID 10775188·Biol Reprod·2000
7-preclinical
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.
PMID 18423407·Adv Enzyme Regul·2008
8-other
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
PMID 18332865·Oncogene·2008
8-other
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
PMID 16854453·Adv Enzyme Regul·2006
8-other
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
PMID 16443741·J Clin Pathol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 243 GEORGIA ST, SUITE B
VALLEJO, CA 94590 - Phone
- (707) 556-8100
Quick Facts
- NPI
- 1427121896
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile